Effect of Time to Dasatinib Initiation On Outcome of Imatinib-Intolerant Patients with Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Results From a European Observational Study (FORTE; CA180–211)

Autor: Marin, David, Morra, Enrica, Michallet, Mauricette, Hellmann, Andrzej, Niederwieser, Dietger, Schloegl, Ernst *, Björeman, Mats *, Foryciarz, Kajetana *, Ho, Aloysius Y, Kuliczkowski, Kazimierz *, Ossenkoppele, Gert, Gozzini, Antonella *, Guerra, M. Lurdes *, Verhoef, Gregor, Mori, Ave *, Pans, Miranda *, van Baardewijk, Marc *, Steegmann, Juan Luis
Zdroj: In Blood 18 November 2011 118(21):1689-1689
Databáze: ScienceDirect